United States: HHS Agenda Signals FDA's Intent To Issue Proposed DSCSA Rules In December 2016

FDA intends to issue long-awaited proposed regulations governing the licensing of prescription drug wholesale distributors and third-party logistics providers ("3PLs") this December, according to the updated 2016 HHS regulatory agenda. Under the Drug Supply Chain Security Act ("DSCSA"), FDA was required to issue these regulations no later than two years following the law's November 2013 enactment; however, that deadline passed on November 27, 2015.

Anticipating the critical guidance the regulations will offer to wholesale distributors and 3PLs, we hope FDA meets its new self-imposed December deadline. The DSCSA requires FDA to issue regulations that (1) update the federal standards governing state licensure of wholesale distributors; (2) establish federal standards governing state licensure of 3PLs; and (3) create a federal system for licensing wholesale distributors and 3PLs. The ongoing lack of updated federal standards for state licensing of wholesale distributors (and the lack of any federal standards for state licensing of 3PLs) since the 2013 enactment of the DSCSA has left the drug supply chain grappling with many issues regarding DSCSA requirements with which they must comply. FDA's proposed regulations – and, in particular, the preamble to such regulations – could clarify these issues.

1. Will FDA comment on the extent to which federal licensing standards preempt state licensing requirements?

The DSCSA restricts states from establishing or continuing state licensing standards or requirements that are "inconsistent with, less stringent than, directly related to, or covered by" the requirements set forth in these new federal licensing standards. Draft Guidance released by FDA in October 2014 suggests that the phrase "inconsistent with" only sets a minimum floor with which state licensing must be equal to or greater. However, some posit that the DSCSA phrase "inconsistent with, less stringent than, directly related to, or covered by" also sets a maximum ceiling of requirements which states may not surpass. They also argue that both a minimum and maximum threshold better align with the intentions of the law.

This issue is particularly relevant as states consider to what extent the federal standards preempt their own state licensing standards or the standards of independent third-party accreditation services. For instance, some states currently require independent accreditation by the National Association of Boards of Pharmacy's (NABP) accreditation program, Verified Accredited Wholesale Distributors (VAWD). VAWD's licensing requirements are considered even more stringent than those of some states. Where inconsistencies in the stringency of state or independent licensing requirements and the federal standards exist, will FDA's new federal standards prevent states from mandating VAWD accreditation for some distributors?

2. How comprehensive and definitive will FDA's guidance be to states on how to implement the new federal licensing standards?

States currently follow the limited federal standards for state licensing of wholesale distributors set forth in Section 205 of the 1987 Prescription Drug Marketing Act (PDMA), and as implemented by FDA in Part 205 of the Code of Federal Regulations. When FDA implemented the PDMA, the agency set a minimum floor of standards with which state licensing must be equal to or greater.

Giving states such broad discretion resulted in a patchwork of differing standards for wholesale distributors. Moving forward, the DSCSA aims to achieve uniformity of wholesale distributor and 3PL licensing. Thus, will FDA acknowledge or account for the risk of patchwork requirements caused by state-by-state implementation of federal licensing standards when issuing new federal standards? For example, FDA could offer comprehensive, reproducible standards to be adopted and implemented by each state with little room for interpretation. FDA could also provide examples of what could fall outside the scope of these new standards (e.g., controlled substances, drug monitoring and reporting programs).

3. Will FDA comment on 3PL licensing in states that do not have their own licensing requirements, and where providers cannot yet benefit from federal licensing?

Under the DSCSA, all 3PLs are required to be licensed as 3PLs (and not wholesale distributors), either by FDA or by states that have implemented their own separate state licensing standards for 3PLs. The federal system for 3PL licensing must be used when a state from which the drug is distributed has not established its own standards. However, the federal system has not yet been created. As a result, the DSCSA's licensure requirement has left 3PLs located in states that do not have their own separate state licensing standards for 3PLs in a bind. They are not yet able to benefit from a federal licensing scheme, and they are in some cases struggling to obtain licensing in the state into which the drugs they warehouse or coordinate are distributed.

4. To what extent will FDA recognize inspection of wholesale distributors by independent accreditors such as VAWD?

FDA's proposed rule will include standards for timely physical inspection of any wholesale distribution facility. Section 583(c) allows the federal or state licensing authority to conduct the required inspections or to accept inspection by an approved third-party accreditation or inspection service. Some states rely on inspections conducted by NABP through its VAWD program, even though NABP's VAWD standards are more stringent than both state and federal law. Will FDA recognize the VAWD program as a potential third-party inspection service? The issue of preemption again is highly pertinent. If FDA recognizes the VAWD program, will it want NABP to establish separate inspection standards that track the DSCSA (and FDA's implementing regulations) and not the more stringent VAWD requirements?

5. Finally, how specifically will FDA address independent accreditation of 3PLs?

Section 584(d)(2)(A) requires FDA to establish a process for the issuance of 3PL licenses by federally-approved third-party accreditation programs (unless no such program meets federal requirements under Section 584(d)(2)(B)). How will FDA structure and manage these third-party programs? What rights will 3PLs have to appeal inspection findings? How will FDA approach enforcement actions against non-compliant 3PLs?

We hope these and many other issues are addressed when FDA issues its proposed regulations in December, though an exact date has not yet been set.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.